Skip to main content
. 2009 Jun 1;296(6):H1748–H1757. doi: 10.1152/ajpheart.00099.2009

Fig. 4.

Fig. 4.

Characterization of nodule formation in day 5 VIC cultures following inhibition of the mitogen-activated protein kinase (MAPK)/ERK pathway via application of U-0126 or PD-98059. A: total nodule number per well. B: average size of nodules. C: total nodule area per well. Values are means ± SD; n = 9 samples per condition. #P < 0.0001 compared with corresponding untreated condition.